Renalytix AI PLC Director/PDMR Shareholding (1932L)

TIDMRENX

RNS Number : 1932L

Renalytix AI PLC

20 December 2018

Renalytix AI plc

("RenalytixAI" or the "Company")

Director/ PDMR Shareholding

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 112 pence per share.

Following this purchase, Mr Mills is interested in 9,199,568 Ordinary Shares representing 17.09% of the total voting rights in the Company.

Enquiries:

 
 Renalytix AI plc                                       www.renalytixai.com 
 James McCullough, CEO                                                  Via Walbrook PR or Tel: +1 646 
                                                                                              397 3970 
                                                   --------------------------------------------------- 
 
 N+1 Singer (Nominated Adviser & Broker)                Tel: [phone] 
                                                       ----------------------------------------------- 
 Aubrey Powell / James White / George Tzimas 
  (Corporate Finance) 
                                                       ----------------------------------------------- 
 Tom Salvesen / Mia Gardner (Corporate Broking) 
                                                       ----------------------------------------------- 
 
 Walbrook PR Limited                                    Tel: [phone] or [e-mail] 
                                                 ----------------------------------------------------- 
 Paul McManus / Lianne Cawthorne                      Mob: [phone] / 07584 
                                                       391 303 
                                                     ------------------------------------------------- 
 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                   Harwood Capital LLP (Harwood) as 
                                               investment manager to North Atlantic 
                                               Smaller Companies Investment Trust 
                                               plc and Oryx 
      ------------------------------------  --------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------- 
 a)    Position/status                       Christopher Mills, non-exec director 
                                              of the issuer and director of NASCIT 
                                              and Oryx International Growth Fund 
                                              Ltd 
      ------------------------------------  --------------------------------------------- 
 b)    Initial notification                  Initial Notification 
        /Amendment 
      ------------------------------------  --------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------- 
 a)    Name                                  Renalytix AI plc 
      ------------------------------------  --------------------------------------------- 
 b)    LEI                                   213800NTOH3FK3WER551 
      ------------------------------------  --------------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------- 
 a)    Description of the                    Ordinary shares of 0.25 pence each 
        financial instrument, 
        type of instrument 
 
       Identification code                   GB00BYWL4Y04 
 
 b)    Nature of the transaction             Share purchase 
      ------------------------------------  --------------------------------------------- 
 c)    Price(s) and volume(s) 
                                             ------------------------  ---------------- 
                                              Price(s)                  Volume(s) 
                                             ------------------------  ---------------- 
    112.00 pence                                                        3,168 
   ------------------------------------------------------------------  ---------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume                   3,168 
 
  - Price                               GBP3,548.16 
 
 e)    Date of the transaction               20 December 2018 
      ------------------------------------  --------------------------------------------- 
 f)    Place of the transaction              London Stock Exchange 
      ------------------------------------  --------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKKDDOBDDFBB

(END) Dow Jones Newswires

December 20, 2018 12:20 ET (17:20 GMT)